DETAILS, FICTION AND SQUALENE

Proteolysis-targeting chimeras (PROTACs) and molecular glue degraders (MGDs) are essentially the most maturely produced TPD strategies. With this evaluate, we deal with both preclinical experiments and clinical trials to provide an extensive summary of the security and medical efficiency of PROTACs and MGDs in hematologic malignancies in the last t